Skip to content
BillHelp
Menu
YOUR BILLHELP GUIDE

Continuous Glucose Monitor Denied by Insurance

What can I do if insurance denies a continuous glucose monitor?

Insurance can deny a continuous glucose monitor. The denial may say the monitor is not medically necessary, that an approval was missing, or that the plan does not cover it as a drug or as equipment. Original Medicare can cover a monitor as durable medical equipment under Part B when you meet the glucose-monitor coverage rules. This page explains those rules, a formulary exception, and the appeal. It does not promise that the monitor will be covered.

Get help with my bill →
General U.S. guidance. Your plan documents and denial notice explain the process that applies to your case. Medicare, Medicaid, and other programs may use different rules. This is not medical or legal advice, and no result is guaranteed.

What should I read on a continuous glucose monitor denial?

Start with the denial or the explanation of benefits. Write down whether the plan says the monitor is not medically necessary, that an approval was missing, that the item is not on the formulary, or that it is not covered equipment. Those are different problems. The next step depends on which one you have. If the denial is for a GLP-1 medicine prescribed for type 2 diabetes, rather than for the monitor, see a diabetes medication denial.

A private plan may require prior authorization before it will pay for the monitor. HealthCare.gov says preauthorization, also called prior authorization, prior approval, or precertification, is the plan's decision that a health care service, treatment plan, prescription drug, or durable medical equipment is medically necessary. A plan may require it before you receive the item, except in an emergency. It is not a promise the plan will pay. If the denial says an approval was missing, ask the plan which benefit it used and what it wanted to see. The general path is in a prior authorization denial.

Original Medicare's glucose-monitor policy requires a standard written order before a claim is submitted. CMS also keeps a Required Prior Authorization List for some equipment, and that list changes. Read the denial before you assume this monitor needed the same approval as a wheelchair or another device. Other equipment rules are in a durable medical equipment denial.

References: HealthCare.gov: Preauthorization · CMS Medicare Coverage Database LCD L33822: Glucose Monitors, DME MACs

What does Medicare require for a continuous glucose monitor?

Medicare.gov says Medicare may cover a continuous glucose monitor and related supplies, such as sensors, under Part B as durable medical equipment if you have diabetes, your doctor or other health care provider orders it, and you meet the conditions on that page. Those conditions are that you take insulin or have a history of problems with low blood sugar, and that you or your caregiver have had enough training to use the monitor as directed. The provider must evaluate you before ordering it. Your doctors and the durable medical equipment supplier must be enrolled in Medicare. After you meet the Part B deductible, you pay 20 percent of the Medicare-approved amount if the supplier accepts assignment. Ask the supplier whether it participates in Medicare before you get the monitor. This page does not state the deductible amount. Use the figure on the current Medicare.gov page.

The detailed rule the durable medical equipment contractors use is local coverage determination L33822, Glucose Monitors, on the Medicare Coverage Database. The page lists all four DME MAC contracts: CGS Administrators for Jurisdictions B and C, and Noridian Healthcare Solutions for Jurisdictions A and D. The revision effective date on that page is for services performed on or after October 1, 2024. Check the Coverage Database before you rely on a printed copy, because a later revision can change the page.

L33822 says that to be eligible for a continuous glucose monitor and related supplies, you must meet all of the initial coverage criteria. You must have diabetes mellitus. Your treating practitioner must conclude that you, or your caregiver, have had sufficient training to use the prescribed monitor, shown by a prescription. The monitor must be prescribed in line with its FDA indications for use. To improve glycemic control, you must be insulin-treated, or you must have a history of problematic hypoglycemia documented in one of the two ways the LCD describes. Within six months before the monitor is ordered, the treating practitioner must have an in-person visit, or a Medicare-approved telehealth visit, to evaluate your diabetes control and decide that those criteria are met.

The LCD describes problematic hypoglycemia as either of the following, and it points to policy article A52464 for the documentation. The first is recurrent level 2 events, meaning more than one, with glucose below 54 mg/dL (3.0 mmol/L), that persist despite more than one attempt to adjust medication or modify the diabetes treatment plan. The second is one level 3 event, also written as glucose below 54 mg/dL (3.0 mmol/L), with an altered mental or physical state that requires third-party assistance to treat the low blood sugar. The LCD also says insulin does not exist in an oral form, so a person who takes only oral medication for diabetes is not insulin-treated under that sentence.

Continued coverage is separate. Every six months after the initial prescription, the treating practitioner must conduct an in-person visit, or a Medicare-approved telehealth visit, to document that you are adhering to the monitor and to the diabetes treatment plan. If any initial criterion, or that continued-coverage visit, is not met, the LCD says the monitor and the related supply allowance are denied as not reasonable and necessary.

Policy article A52464 explains when a monitor counts as durable medical equipment. It says a monitor that only displays results on a smartphone, and that does not have a stand-alone receiver or integration into an insulin infusion pump, does not meet the definition of durable medical equipment and is denied as non-covered. Medicare coverage of the supply allowance is available when you use a stand-alone receiver, or an insulin pump classified as durable medical equipment, to display the glucose data. A phone, watch, tablet, or similar device may be used together with that durable receiver. The article says smart devices themselves are not covered as durable medical equipment. The LCD also says a standard written order must reach the supplier before a claim is submitted. A claim without that order is denied as not reasonable and necessary.

References: Medicare.gov: Continuous glucose monitors · CMS Medicare Coverage Database LCD L33822: Glucose Monitors, DME MACs · CMS Medicare Coverage Database article A52464: Glucose Monitor policy article

Is the monitor a pharmacy benefit or durable medical equipment?

Original Medicare treats a covered continuous glucose monitor as durable medical equipment under Part B. Medicare.gov labels it Part B and DME. It is not a Part D formulary drug under the pages cited here. Do not send a Part B equipment denial through a Part D drug appeal.

A private plan can process the same kind of device under a pharmacy benefit or under a medical or equipment benefit. The denial and the explanation of benefits show which one that plan used. If the plan says the item is not on the formulary, use the drug-benefit path below. If the plan says the equipment is not medically necessary, or that an approval was missing, use the medical-benefit appeal. Ask the plan, in writing, which benefit it applied. How to read the two columns is in how an explanation of benefits differs from a bill.

References: Medicare.gov: Continuous glucose monitors · CMS Medicare Coverage Database article A52464: Glucose Monitor policy article · HealthCare.gov: Formulary

How does a formulary exception work?

A formulary exception applies when the plan treats the monitor, or its sensors, as a prescription drug and the drug is not on the formulary. HealthCare.gov describes a formulary as the list of drugs a plan covers. It does not turn an Original Medicare equipment claim into a drug claim.

For a health plan that provides essential health benefits, 45 CFR 156.122(c) requires a process for you, your designee, or your prescribing physician or other prescriber to request a clinically appropriate drug the plan does not otherwise cover. For a standard exception, the plan must decide and notify you or your designee and the prescriber no later than 72 hours after it receives the request. For an expedited request, the plan must decide and notify no later than 24 hours after it receives the request. Exigent circumstances exist when you are suffering from a health condition that may seriously jeopardize your life, health, or ability to regain maximum function, or when you are undergoing a current course of treatment using a non-formulary drug. If the plan grants a standard exception, it must cover the drug for the duration of the prescription, including refills. If it grants an expedited exception, it must cover the drug for the duration of the exigency.

If the plan denies the standard or expedited exception, 45 CFR 156.122(c)(3) says you, your designee, or your prescriber can ask an independent review organization to review that denial. The plan must decide that external exception request no later than 72 hours after it receives a standard request, and no later than 24 hours after it receives an expedited request. A state may treat a plan as meeting this section when the state's coverage appeals laws are at least as stringent, include an internal review, an external review, and a way to expedite, and use timeframes that are the same or shorter. A plan that does not provide essential health benefits, which can include some large employer plans and some self-funded plans, may not use this section. Ask the plan whether it provides essential health benefits, and follow the process on the denial if it names a different one. The drug-list steps are also in a drug that is not on the formulary.

References: HealthCare.gov: Formulary · 45 CFR 156.122: Essential health benefit prescription drug exceptions

How do I appeal a continuous glucose monitor denial?

For an Original Medicare claim, 42 CFR 405.942 says a redetermination must be filed within 120 calendar days after you receive the notice of the initial determination. Receipt is presumed five calendar days after the date on the notice, unless there is evidence otherwise. The steps, including what to send, are in how to appeal an Original Medicare denial. Send the order, the visit note from the six-month evaluation, and the records that match the criterion the denial says you missed. Do not ask anyone to create a note for a visit that did not happen.

A Medicare Advantage plan must comply with written coverage decisions of the local Medicare contractors with jurisdiction for claims in the plan's geographic area, under 42 CFR 422.101(b)(3). L33822 is the glucose-monitor local coverage determination for the DME MACs listed on that Coverage Database page. If the plan denies the Part B equipment benefit, ask it to identify the criteria it used. The plan's own appeal is in how to appeal a Medicare Advantage denial. Do not send that denial to an Original Medicare contractor.

For a private plan that is not Medicare, use the internal appeal on the denial notice. HealthCare.gov explains that appeal. If the plan finishes its own review, or the care is urgent, an external review may be available. That path is in how to request an external review. A medical-necessity denial is in a medical necessity denial. Use the address and the deadline on your notice. Do not send a private-plan denial to a Medicare contractor.

References: 42 CFR 405.942: Original Medicare redetermination filing deadline · Medicare.gov: Appeals in Original Medicare · 42 CFR 422.101: Medicare Advantage basic benefits, including traditional Medicare coverage criteria · CMS Medicare Coverage Database LCD L33822: Glucose Monitors, DME MACs · HealthCare.gov: Internal appeals · HealthCare.gov: External review

What this page cannot promise

This is general information, not medical or legal advice. A monitor can fail the LCD criteria and still be something your clinician wants you to use. A formulary exception applies to a drug benefit, not to every equipment denial. An appeal can leave the denial in place. Nothing on this page promises that Medicare or a plan will cover a continuous glucose monitor, or that a supplier will cancel a bill.

Sources and further help

These sources provide general guidance. For a deadline or requirement that applies to you, follow your plan’s notice or the appropriate program’s current instructions.

Insurer websites may ask you to select your state or sign in. If a page will not open, use the member services number on your insurance card and ask for the current appeal instructions for your plan.

Report a broken link or suggest a correction.

← Explore all 141 guides